An expert team supporting advances in respiratory therapeutics

Respiratory & Pulmonary Diseases

Access comprehensive pulmonary and respiratory clinical trial capabilities spanning Phase I-IV, real-world evidence (RWE), digital health technologies and diversity action planning.

Get a competitive edge with Fortrea’s site-level data and patient- and site-centric solutions to compete in today’s rapidly growing market.

Advance your treatment to market quickly and effectively with the combination of our industry experts and capabilities.

Our patient- and site-centric point of view helps us shape successful respiratory and pulmonary disease studies. Learn how our experienced teams strive to be more than a partner as we help make your respiratory trial more attractive to potential participants, promote increased recruitment and retention rates, support diversity requirements and help your study stand out in today's highly competitive environment.

In the last 5 years

We’ve been honored to serve as a partner of choice for our biotech and pharmaceutical customers as we’ve advanced their respiratory drug development and supported:

380+

Respiratory studies

14.500+

Sites

304.000+

Pacientes

Top Indications

Asthma  |  Chronic obstructive pulmonary disease (COPD)  |  Idiopathic pulmonary fibrosis (IPF)  |  Cystic fibrosis (CF)

Why choose Fortrea for your next respiratory trial?

Fortrea provides access to industry experts to support protocol design, operational strategists to ensure the most efficient clinical plan and budget along with experienced operational teams to meet your study delivery expectations for diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), progressive pulmonary fibrosis (PPF) and more.

Get to know us

An exceptional partnership starts with an experienced team. Browse the bios of our featured team members.

Select high-performing sites across your program

Advance your program with the right, high-performing sites. We have an extensive set of site-level data to use historical performance as a guide for site selection along with strong network partnerships and experienced sites specialized in pulmonary/respiratory diseases. Our experience and data provide greater confidence in site selection and enrollment timelines and enable us to deliver to your expectations.

Beyond our existing partnerships with sites, we are constantly pursuing additional sites as we expand our network globally—including sites in emerging regions such as Latin America, Asia and Africa—to continuously optimize patient recruitment in a competitive environment.

Your partner for comprehensive respiratory clinical trials

Whether you need support with early-phase adaptive trial design, site selection, patient identification or targeted services for late-phase respiratory trials, trust the expertise of an agile and experienced partner. Our dedicated, global respiratory team serves as a committed partner with the expertise and experience to deliver a comprehensive trial solution that fits your organization's business and strategy.

Fique por dentro:
Inscreva-se para receber notícias e anúncios da Fortrea.